Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1136/bmj.a2097

Type

Journal article

Journal

BMJ

Publication Date

20/11/2008

Volume

337

Keywords

Clostridium difficile, Cross Infection, Enterocolitis, Pseudomembranous, Health Policy, Humans, Primary Health Care, Reimbursement, Incentive, State Medicine, United Kingdom